Dietary Flavonoid Intake and Smoking-Related Cancer Risk: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Woo, Hae Dong ^a   Kim, Jeongseon ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIDIN DERIVATIVE; CATECHIN; EPICATECHIN; FLAVAN 3 OL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; HESPERETIN; ISOFLAVONE DERIVATIVE; KAEMPFEROL; LUTEOLIN; MYRICETIN; NARINGENIN; PLANT MEDICINAL PRODUCT; PROANTHOCYANIDIN; QUERCETIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; ESOPHAGUS CANCER; FEMALE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MOUTH CANCER; OBSERVATIONAL STUDY; PANCREAS CANCER; PHARYNX CANCER; RISK ASSESSMENT; RISK REDUCTION; SMOKING; STOMACH CANCER; SYSTEMATIC REVIEW; TRANSITIONAL CELL CARCINOMA;

CASE-CONTROL STUDIES; COHORT STUDIES; DIET; FEMALE; FLAVONOIDS; HUMANS; MALE; NEOPLASMS; ODDS RATIO; RISK; SMOKING;

EID: 84884398142     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075604     Document Type: Article

References (59)

1. Williams DE, Prevost AT, Whichelow MJ, Cox BD, Day NE, et al. (2000) A cross-sectional study of dietary patterns with glucose intolerance and other features of the metabolic syndrome. Br J Nutr 83: 257-266. doi:10.1017/S0007114500000337. PubMed: 10884714.
2. Suwazono Y, Nogawa K, Uetani M, Miura K, Sakata K, et al. (2011) Application of hybrid approach for estimating the benchmark dose of urinary cadmium for adverse renal effects in the general population of Japan. J Appl Toxicol 31: 89-93. doi:10.1002/jat.1582. PubMed: 20836141.
3. Ohshima H, Yoshie Y, Auriol S, Gilibert I, (1998) Antioxidant and pro-oxidant actions of flavonoids: effects on DNA damage induced by nitric oxide, peroxynitrite and nitroxyl anion. Free Radic Biol Med 25: 1057-1065. doi:10.1016/S0891-5849(98)00141-5. PubMed: 9870559.
4. Dickancaité E, Nemeikaitè A, Kalvelytè A, Cènas N, (1998) Prooxidant character of flavonoid cytotoxicity: structure-activity relationships. Biochem Mol Biol Int 45: 923-930. PubMed: 9739457.
5. Pietta PG, (2000) Flavonoids as antioxidants. J Nat Prod 63: 1035-1042. doi:10.1021/np9904509. PubMed: 10924197.
6. García-Lafuente A, Guillamón E, Villares A, Rostagno MA, Martínez JA, (2009) Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 58: 537-552. doi:10.1007/s00011-009-0037-3. PubMed: 19381780.
7. Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, et al. (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74: 418-425. PubMed: 11566638.
8. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, et al. (2004) Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 96: 99-106. doi:10.1093/jnci/djh014. PubMed: 14734699.
9. Woo HD, Kim J, (2013) Dietary flavonoid intake and risk of stomach and colorectal cancer. World J Gastroenterol 19: 1011-1019. doi:10.3748/wjg.v19.i7.1011. PubMed: 23467443.
10. Mutoh M, Takahashi M, Fukuda K, Komatsu H, Enya T, et al. (2000) Suppression by Flavonoids of Cyclooxygenase-2 Promoter-dependent Transcriptional Activity in Colon Cancer Cells: Structure-Activity Relationship. Cancer Sci 91: 686-691. doi:10.1111/j.1349-7006.2000.tb01000.x.
11. Suh Y, Afaq F, Johnson JJ, Mukhtar H, (2009) A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-κB-signaling pathways. Carcinogenesis 30: 300-307. PubMed: 19037088.
12. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, et al. (1990) The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260: 10-13. doi:10.1016/0014-5793(90)80053-L. PubMed: 2298289.
13. Garcia-Closas R, Agudo A, Gonzalez CA, Riboli E, (1998) Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer 32: 154-158. doi:10.1080/01635589809514734. PubMed: 10050265.
14. Garcia R, Gonzalez CA, Agudo A, Riboli E, (1999) High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutr Cancer 35: 212-214. doi:10.1207/S15327914NC352_18. PubMed: 10693178.
15. Garcia-Closas R, Gonzalez CA, Agudo A, Riboli E, (1999) Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control 10: 71-75. doi:10.1023/A:1008867108960. PubMed: 10334645.
16. De Stefani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Carzoglio JC, et al. (1999) Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer 34: 100-110. doi:10.1207/S15327914NC340114. PubMed: 10453448.
17. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN, (2000) Intake of flavonoids and lung cancer. J Natl Cancer Inst 92: 154-160. doi:10.1093/jnci/92.2.154. PubMed: 10639518.
18. Lagiou P, Samoli E, Lagiou A, Katsouyanni K, Peterson J, et al. (2004) Flavonoid intake in relation to lung cancer risk: case-control study among women in Greece. Nutr Cancer 49: 139-143. doi:10.1207/s15327914nc4902_4. PubMed: 15489206.
19. Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, et al. (2004) Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 15: 67-72. doi:10.1023/B:CACO.0000016619.18041.b0. PubMed: 14970736.
20. Schabath MB, Hernandez LM, Wu X, Pillow PC, Spitz MR, (2005) Dietary phytoestrogens and lung cancer risk. JAMA 294: 1493-1504. doi:10.1001/jama.294.12.1493. PubMed: 16189362.
21. Bosetti C, Rossi M, McLaughlin JK, Negri E, Talamini R, et al. (2007) Flavonoids and the risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 16: 98-101. doi:10.1158/1055-9965.EPI-06-0769. PubMed: 17220336.
22. Garavello W, Rossi M, McLaughlin JK, Bosetti C, Negri E, et al. (2007) Flavonoids and laryngeal cancer risk in Italy. Ann Oncol 18: 1104-1109. doi:10.1093/annonc/mdm078. PubMed: 17372161.
23. Rossi M, Garavello W, Talamini R, La Vecchia C, Franceschi S, et al. (2007) Flavonoids and risk of squamous cell esophageal cancer. Int J Cancer 120: 1560-1564. doi:10.1002/ijc.22499. PubMed: 17192901.
24. Rossi M, Garavello W, Talamini R, Negri E, Bosetti C, et al. (2007) Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiol Biomarkers Prev 16: 1621-1625. doi:10.1158/1055-9965.EPI-07-0168. PubMed: 17684136.
25. Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT, et al. (2008) Dietary flavonoid intake and lung cancer-A population-based case-control study. Cancer 112: 2241-2248. doi:10.1002/cncr.23398. PubMed: 18327817.
26. Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C, et al. (2008) Flavonoid intake and liver cancer: a case-control study in Greece. Cancer Causes Control 19: 813-818. doi:10.1007/s10552-008-9144-7. PubMed: 18350370.
27. Bobe G, Peterson JJ, Gridley G, Hyer M, Dwyer JT, et al. (2009) Flavonoid consumption and esophageal cancer among black and white men in the United States. Int J Cancer 125: 1147-1154. doi:10.1002/ijc.24421. PubMed: 19444905.
28. Rossi M, Rosato V, Bosetti C, Lagiou P, Parpinel M, et al. (2010) Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes Control 21: 1597-1604. doi:10.1007/s10552-010-9588-4. PubMed: 20521092.
29. Ekström AM, Serafini M, Nyrén O, Wolk A, Bosetti C, et al. (2011) Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Ann Oncol 22: 438-443. doi:10.1093/annonc/mdq390. PubMed: 20688844.
30. Christensen KY, Naidu A, Parent MÉ, Pintos J, Abrahamowicz M, et al. (2012) The Risk of Lung Cancer Related to Dietary Intake of Flavonoids. Nutr Cancer 64: 964-974. doi:10.1080/01635581.2012.717677. PubMed: 23061904.
31. Rossi M, Lugo A, Lagiou P, Zucchetto A, Polesel J, et al. (2012) Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in Italy. Ann Oncol 23: 1488-1493. doi:10.1093/annonc/mdr475. PubMed: 22052986.
32. Arts ICW, Hollman PCH, Bueno de Mesquita HB, Feskens EJM, Kromhout D, (2001) Dietary catechins and epithelial cancer incidence: the Zutphen elderly study. Int J Cancer 92: 298-302. doi:10.1002/1097-0215(200102)9999:9999. PubMed: 11291060.
33. Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P, (2001) Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control 12: 797-802. doi:10.1023/A:1012273806199. PubMed: 11714106.
34. Arts ICW, Jacobs DR, Gross M, Harnack LJ, Folsom AR, (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control 13: 373-382. doi:10.1023/A:1015290131096. PubMed: 12074507.
35. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, et al. (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76: 560-568. PubMed: 12198000.
36. Wright ME, Mayne ST, Stolzenberg-Solomon RZ, Li Z, Pietinen P, et al. (2004) Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers. Am J Epidemiol 160: 68-76. doi:10.1093/aje/kwh173. PubMed: 15229119.
37. Nöthlings U, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN, (2007) Flavonols and pancreatic cancer risk. Am J Epidemiol 166: 924-931. doi:10.1093/aje/kwm172. PubMed: 17690219.
38. Bobe G, Weinstein SJ, Albanes D, Hirvonen T, Ashby J, et al. (2008) Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiol Biomarkers Prev 17: 553-562. doi:10.1158/1055-9965.EPI-07-2523. PubMed: 18349272.
39. Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR Jr, et al. (2008) Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer 123: 664-671. doi:10.1002/ijc.23564. PubMed: 18491403.
40. Mursu J, Nurmi T, Tuomainen TP, Salonen JT, Pukkala E, et al. (2008) Intake of flavonoids and risk of cancer in Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Cancer 123: 660-663. doi:10.1002/ijc.23421. PubMed: 18338754.
41. Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizokami M, et al. (2009) Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women. Int J Cancer 124: 1644-1649. doi:10.1002/ijc.24121. PubMed: 19089922.
42. Wang L, Lee IM, Zhang SM, Blumberg JB, Buring JE, et al. (2009) Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr 89: 905-912. doi:10.3945/ajcn.2008.26913. PubMed: 19158208.
43. Bertoia M, Albanes D, Mayne ST, Männistö S, Virtamo J, et al. (2010) No association between fruit, vegetables, antioxidant nutrients and risk of renal cell carcinoma. Int J Cancer 126: 1504-1512. PubMed: 19685494.
44. Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Sawada N, et al. (2010) Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan. Am J Clin Nutr 91: 722-728. doi:10.3945/ajcn.2009.28161. PubMed: 20071645.
45. Hara A, Sasazuki S, Inoue M, Iwasaki M, Shimazu T, et al. (2012) Isoflavone intake and risk of gastric cancer: a population-based prospective cohort study in Japan. Am J Clin Nutr 95: 147-154. doi:10.3945/ajcn.111.020479. PubMed: 22170362.
46. Zamora-Ros R, Agudo A, Luján-Barroso L, Romieu I, Ferrari P, et al. (2012) Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 96: 1398-1408. doi:10.3945/ajcn.112.037358. PubMed: 23076618.
47. Tang NP, Zhou B, Wang B, Yu RB, Ma J, (2009) Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol 39: 352-359. doi:10.1093/jjco/hyp028. PubMed: 19351659.
48. Bravo L, (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56: 317-333. doi:10.1111/j.1753-4887.1998.tb01670.x. PubMed: 9838798.
49. Deng W, Fang X, Wu J, (1997) Flavonoids function as antioxidants: by scavenging reactive oxygen species or by chelating iron? Radiat Phys Chem 50: 271-276. doi:10.1016/S0969-806X(97)00037-6.
50. Hollman PCH, Cassidy A, Comte B, Heinonen M, Richelle M, et al. (2011) The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr 141: 989S-1009S. doi:10.3945/jn.110.131490. PubMed: 21451125.
51. Mladenka P, Zatloukalová L, Filipský T, Hrdina R, (2010) Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic Biol Med 49: 963-975. doi:10.1016/j.freeradbiomed.2010.06.010. PubMed: 20542108.
52. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C, (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230S-242S. PubMed: 15640486.
53. Moon YJ, Wang X, Morris ME, (2006) Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20: 187-210. doi:10.1016/j.tiv.2005.06.048. PubMed: 16289744.
54. Buiatti E, Muñoz N, Kato I, Vivas J, Muggli R, et al. (1998) Determinants of plasma anti-oxidant vitamin levels in a population at high risk for stomach cancer. Int J Cancer 65: 317-322.
55. Delgado ME, Haza AI, Arranz N, García A, Morales P, (2008) Dietary polyphenols protect against N-nitrosamines and benzo (a) pyrene-induced DNA damage (strand breaks and oxidized purines/pyrimidines) in HepG2 human hepatoma cells. Eur J Nutr 47: 479-490. doi:10.1007/s00394-008-0751-6. PubMed: 18974940.
56. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, et al. (1998) Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58: 4858-4863. PubMed: 9809991.
57. Schwarz D, Kisselev P, Roots I, (2005) CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin. Eur J Cancer 41: 151-158. doi:10.1016/j.ejca.2004.08.011. PubMed: 15618000.
58. Neuhouser ML, (2004) Review: Dietary flavonoids and cancer risk: Evidence from human population studies. Nutr Cancer 50: 1-7. doi:10.1207/s15327914nc5001_1. PubMed: 15572291.
59. Le Marchand L, (2002) Cancer preventive effects of flavonoids-a review. Biomed Pharmacother 56: 296-301. doi:10.1016/S0753-3322(02)00186-5. PubMed: 12224601.